LeadR Profile

{{ forename }} {{ lastname }}{{ getFilteredTitles("first") }}{{ getFilteredTitles("second") }} Charité - University Medicine Berlin Germany
4 699 ScienceLeadR Reputation 4699
Network Map

Oncology

Subspecialties: Gynecology - Obstetrics

Full career Last 3 years

Main Topics

Publications and Clinical Studies

Publications Clinical Studies

Short Biography

Jalid Sehouli is Professor of Gynecology and Gynecologic Oncology at Charité – Universitätsmedizin Berlin and one of Europe’s leading experts in the treatment of gynecologic malignancies. He is President of the PanArabian Research Society of Gynecologic Oncology (PARSGO) and serves in multiple leadership roles within international oncology networks. From 2026, he will assume the presidency of the European Society of Gynaecological Oncology (ESGO). He is the founder of the North-Eastern German Society for Gynecological Oncoogy (NOGGO) and the founder of the German Ovarian Cancer Foundation.

His clinical and scientific focus includes ovarian, endometrial and cervical cancer, rare gynecologic tumors, long-term survivorship, patient-centered care, and communication in medicine. He has authored and co-authored more than 1,000 scientific publications and has led numerous national and international clinical trials.

Beyond his medical career, Jalid Sehouli is an award-winning writer and essayist whose work explores themes of identity, migration, trauma, and healing at the intersection of medicine and literature. His book The Art of Breaking Bad News is regarded as a standard reference in medical communication.

Organizations

Source: Pubmed

{{ exp.name }}

Publications Synthesis

Source: Pubmed

Number : 1344

Citations

Citations: 40 010 1st author: 101 Last author: 370 Unique author: 10

Main journals

J Clin Oncol 171
Int J Gynecol Cancer 125
Geburtshilfe Frauenheilkd 108
Anticancer Res 92
Ann Oncol 73

Best Journals

J Clin Oncol 53
Ann Oncol 31
Lancet Oncol 11

Breakdown by type

Clinical Studies 63

Source: ClinicalTrials

Synthesis

Principal Investigator: 14 Study Chair: 1

By phase:

Phase 3 24
Phase 2 17
N/A 15
Phase 1/Phase 2 5
Phase 2/Phase 3 1
Phase 4 1

By status:

Completed 38
Terminated 8
Recruiting 7
Unknown 6
Active not recruiting 4

By type:

Interventional 56
Observational 7

By Monocentric/Multicentric:

monocentric 18
multicentric2to4 3
multicentric5to9 4
multicentricup10 38

Main Topics

Female Urogenital Diseases and Pregnancy Complications 51
Endocrine System Diseases 42
Digestive System Diseases 7
Immune System Diseases 7
Nervous System Diseases 2
Respiratory Tract Diseases 2
Skin and Connective Tissue Diseases 2

Cohort/Consortium Investigators 3

LeadR Networks

Main global connection map

Source: Pubmed Source: ClinicalTrials